Analyst Research

Report Title Price
Provider : Stock Traders Daily
Provider : Thomson Reuters Stock Report
Provider : Jefferson Research
Provider : New Constructs, LLC

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

NeoGenomics Inc gives Q2 2014 guidance above analysts' estimates; raises FY 2014 guidance

Wednesday, 23 Apr 2014 07:00am EDT 

NeoGenomics Inc:Expects Q2 2014 revenue of $18.8-$19.3 mln and net income of $0.00 to $0.01 per share.Increases its guidance for FY 2014.Previously the company stated that it expected revenue of $73-$77 mln if NCCI FISH matter was resolved positively with earnings of $0.05 to $0.07 per share.Says that it now believes that it can achieve $73-$77 mln of revenue even if the NCCI matter is not resolved positively and earnings of $0.03 to $0.05 per share for FY 2014.Q2 2014 revenue of $17.7 mln and EPS of $(0.01) - Thomson Reuters I/B/E/S.FY 2014 revenue of $72 mln and EPS of $0.01 - Thomson Reuters I/B/E/S. 

Company Quote

-0.02 -0.25%
27 Nov 2015